Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Roudy Farah
University of Montreal - Department of Microbiology, Infectious Diseases and Immunology
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
25
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Spike-Accum® Bioconjugate Protein Vaccine Confers Potent SARS-COV-2-Specific Immunity
Number of pages: 62
Posted: 02 Dec 2024
Jean Pierre Bikorimana
,
Nathanael A. Caveney
,
Nehme El-Hachem
,
Gabrielle Arona Mandl
,
John A. Capobianco
,
Daniela Stanga
,
Jamilah Abusarah
,
Mark Hancock
, Roudy Farah,
Marina Gonçalves
,
Darryl Falzarano
,
Mingmin Liao
,
Glenn Hamonic
,
Qiang Liu
,
Simon Beaudoin
,
Sebastien Talbot
,
Moutih Rafei
and
Sneak Peek Administrator
University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Toronto, University of Montreal - CHU Sainte-Justine Research Center, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, Concordia University, Defence Therapeutics Inc, University of Montreal - Department of Pharmacology and Physiology, McGill University, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, Defence Therapeutics Inc, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Defence Therapeutics Inc, Queen’s University, University of Montreal - Department of Pharmacology and Physiology and Independent
Downloads
14
(1,249,763)
View PDF
Download
Abstract:
2.
Forced Intracellular Degradation of Xenoantigens as a Novel Modality for Cell-Based Cancer Immunotherapy
Number of pages: 40
Posted: 13 Nov 2024
Jean Pierre Bikorimana
, Roudy Farah,
Jamilah Abusarah
,
Gabrielle Arona Mandl
,
Mohamed Ali Erregragui
,
Marina Pereira
,
Sebastien Talbot
,
Perla Matar
,
Malak Lahrichi
,
Nehme El-Hachem
,
Moutih Rafei
and
Sneak Peek Administrator
University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, Queen’s University, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, University of Montreal - CHU Sainte-Justine Research Center, University of Montreal - Department of Pharmacology and Physiology and Independent
Downloads
11
(1,281,697)
View PDF
Download
Abstract:
Feedback